Third Circuit overturns pay-for-delay dismissals
Plaintiffs need not calculate likely damages to be obtained from patent litigation - nor various other factors - to plausibly allege that a pharmaceutical company cut a deal with a would-be generic competitor that violates antitrust law, a federal appellate court has held.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10